Open AccessStructural characterization of scorpion peptides and their bactericidal activity against clinical isolates of multidrug-resistant bacteria
Author(s) -
Catherine Cesa-Luna,
Jesús MuñozRojas,
Gloria SaabRincón,
Antonino Baez,
Yolanda Elizabeth Morales-García,
Víctor Rivelino Juárez-González,
Verónica Quintero-Hernández
Publication year - 2019
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0222438
Subject(s) - antimicrobial peptides , antimicrobial , microbiology and biotechnology , bacteria , multiple drug resistance , biology , pathogenic bacteria , peptide , antibiotics , scorpion venoms , scorpion , venom , biochemistry , genetics
Scorpion venom peptides represent a novel source of antimicrobial peptides (AMPs) with broad-spectrum activity. In this study, we determined the minimum bactericidal concentration (MBC) of three scorpion AMPs, Uy234, Uy17, and Uy192, which are found in the venomous glands of the Urodacus yaschenkoi scorpion, against the clinical isolates of multidrug-resistant (MDR) bacteria. In addition, we tested the activity of a consensus AMP designed in our laboratory based on some previously reported IsCT-type (cytotoxic linear peptide) AMPs with the aim of obtaining higher antimicrobial activity. All peptides tested showed high antimicrobial activity against MDR clinical isolates, with the highest activity against β-hemolytic Streptococcus strains. The hemolytic activity was determined against human red blood cells and was significantly lower than that of previously reported AMPs. The α-helical structure of the four AMPs was confirmed by circular dichroism (CD). These results suggest that the four peptides can be valuable tools for the design and development of AMPs for use in the inhibition of MDR pathogenic bacteria. A clear index of synergism and additivity was found for the combination of QnCs-BUAP + Uy234, which makes these peptides the most promising candidates against pathogenic bacteria.